327 related articles for article (PubMed ID: 27189238)
21. Complex robotic-enhanced percutaneous coronary intervention.
Kapur V; Smilowitz NR; Weisz G
Catheter Cardiovasc Interv; 2014 May; 83(6):915-21. PubMed ID: 24167108
[TBL] [Abstract][Full Text] [Related]
22. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
23. Effects of Impella on Coronary Perfusion in Patients With Critical Coronary Artery Stenosis.
Alqarqaz M; Basir M; Alaswad K; O'Neill W
Circ Cardiovasc Interv; 2018 Apr; 11(4):e005870. PubMed ID: 29643128
[TBL] [Abstract][Full Text] [Related]
24. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
Barlis P; Horrigan M; Elis S; Chan R; Wong M; Farouque O; Proimos G; Ajani AE; Clark DJ
Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165
[TBL] [Abstract][Full Text] [Related]
25. Use of the Impella 2.5 for prophylactic circulatory support during elective high-risk percutaneous coronary intervention.
Alasnag MA; Gardi DO; Elder M; Kannam H; Ali F; Petrina M; Kheterpal V; Hout MS; Schreiber TL
Cardiovasc Revasc Med; 2011; 12(5):299-303. PubMed ID: 21454139
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous Mechanical Circulatory Support Devices for High-Risk Percutaneous Coronary Intervention.
Kar S
Curr Cardiol Rep; 2018 Jan; 20(1):2. PubMed ID: 29350305
[TBL] [Abstract][Full Text] [Related]
27. Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.
Carrié D; Eltchaninoff H; Lefèvre T; Silvestri M; Brunel P; Fajadet J; Moynagh A; Gilard M; Koning R; Dibie A; Darremont O; Lablanche JM; Blanchard D;
EuroIntervention; 2011 Oct; 7(6):680-8. PubMed ID: 21986326
[TBL] [Abstract][Full Text] [Related]
28. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy).
Conrotto F; Scacciatella P; D'Ascenzo F; Chieffo A; Latib A; Park SJ; Kim YH; Onuma Y; Capranzano P; Jegere S; Makkar R; Palacios I; Buszman P; Chakravarty T; Mehran R; Naber C; Margey R; Leon M; Moses J; Fajadet J; Lefèvre T; Morice MC; Erglis A; Tamburino C; Alfieri O; D'Amico M; Marra S; Serruys PW; Colombo A; Meliga E
Am J Cardiol; 2014 Jun; 113(12):2007-12. PubMed ID: 24793677
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.
Fanggiday JC; Stella PR; Guyomi SH; Doevendans PA
Catheter Cardiovasc Interv; 2008 Apr; 71(5):629-35. PubMed ID: 18360855
[TBL] [Abstract][Full Text] [Related]
32. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
[TBL] [Abstract][Full Text] [Related]
33. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
[TBL] [Abstract][Full Text] [Related]
34. Procedural outcomes with use of the flash ostial system in aorto-coronary ostial lesions.
Nguyen-Trong PJ; Martinez Parachini JR; Resendes E; Karatasakis A; Danek BA; Alame A; Makke LB; Ayers CR; Roesle M; Rangan B; Banerjee S; Brilakis ES
Catheter Cardiovasc Interv; 2016 Dec; 88(7):1067-1074. PubMed ID: 27259089
[TBL] [Abstract][Full Text] [Related]
35. Guideliner catheter--friend or foe?
Murphy JC; Spence MS
Catheter Cardiovasc Interv; 2012 Sep; 80(3):447-50. PubMed ID: 21805587
[TBL] [Abstract][Full Text] [Related]
36. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous left ventricular support for high-risk PCI and cardiogenic shock: who gets what?
Shah R; Thomson A; Atianzar K; Somma K; Mehra A; Clavijo L; Matthews RV; Shavelle DM
Cardiovasc Revasc Med; 2012; 13(2):101-5. PubMed ID: 22406055
[TBL] [Abstract][Full Text] [Related]
38. Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial.
Henriques JP; Claessen BE; Dangas GD; Kirtane AJ; Popma JJ; Massaro JM; Cohen BM; Ohman EM; Moses JW; O'Neill WW
Int J Cardiol; 2015; 189():272-8. PubMed ID: 25909982
[TBL] [Abstract][Full Text] [Related]
39. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.
Erglis A; Narbute I; Kumsars I; Jegere S; Mintale I; Zakke I; Strazdins U; Saltups A
J Am Coll Cardiol; 2007 Aug; 50(6):491-7. PubMed ID: 17678730
[TBL] [Abstract][Full Text] [Related]
40. Feasibility of complex coronary intervention in combination with percutaneous aortic valve implantation in patients with aortic stenosis using percutaneous left ventricular assist device (TandemHeart).
Piazza N; Serruys PW; de Jaegere P
Catheter Cardiovasc Interv; 2009 Feb; 73(2):161-6. PubMed ID: 19160444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
